Skip to main content

Featured Supplement: 13th C1-inhibitor Deficiency & Angioedema Workshop 2023

The program and book of abstracts from the 13th C1-inhibitor Deficiency & Angioedema Workshop held in Budapest, Hungary, May 2023 are now available to read.


  1. Authors: Peter Small, Paul K. Keith and Harold Kim

Aims and scope

Allergy, Asthma & Clinical Immunology (AACI), the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI), is an open access journal that encompasses all aspects of diagnosis, epidemiology, prevention and treatment of allergic and immunologic disease.

AACI reports on basic research and clinically applied studies in the following areas and other related topics: asthma and occupational lung disease, rhinoconjunctivitis and rhinosinusitis, drug hypersensitivity, allergic skin diseases, urticaria and angioedema, venom hypersensitivity, anaphylaxis and food allergy, immunotherapy, immune modulators and biologics, immune deficiency and autoimmunity, T cell and B cell functions, regulatory T cells, natural killer cells, mast cell and eosinophil functions, complement abnormalities.

Editorial Board


Harold Kim, MD, FRCPC, Western University & McMaster University, Canada

Associate Editors

Philippe Bégin, MD, PhD, FRCPC, FAAAAI, Université de Montréal, Canada
Anne Ellis, MD, MSc, FRCPC, Queen's University, Canada
Jean S Marshall, PhD, Dalhousie University, Canada
Matthieu Picard, MD, FRCPC, Université de Montréal, Canada
Julie Upton, MD, FRCPC, MPH, The Hospital for Sick Children, Canada
Harissios Vliagoftis, MD, PhD, University of Alberta, Canada
Wade Watson, MD, MEd, Dalhousie University, Canada

View more

New Content ItemCelebrating 10 years of open access

Highlighting the key milestones and achievements in Allergy, Asthma and Clinical Immunology, this timeline takes a journey of the past 10 open access years.

From the most mentioned research article to the latest practical guides in allergy and immunology in Canada, this infographic celebrates the impact of the journal's content from 2009-2019. With nearly 6,000 online mentions, and a monthly average of 70,000 accesses and downloads, AACI continues to be a high-visibility forum for new insights and discussions within the allergy and clinical immunology research community for the next 10 years and beyond.

A large, downloadable version of the infographic is available here.

About the CSACI

AACI is the official journal of the Canadian Society of Allergy and Clinical Immunology (CSACI). The CSACI is the largest national professional medical specialty organization in Canada representing allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic diseases.

The CSACI was founded in 1945 to fulfill the following goals: improving the standards of teaching and the practice of allergy and clinical immunology; fostering co-operation between those engaged in the study and practice of allergy and clinical immunology; encourage research in the field of allergy and clinical immunology.

The CSACI represents over 475 (Canadian and international) members who are from all parts of the country including rural areas, cities, community hospitals and academic university teaching centres. The CSACI remains committed to supporting allergists and clinical immunologists in maintaining the pre-eminence of both research and education in Canada. Moving forward, the CSACI will support these aims to ensure that high quality health care is available to all our patients throughout our communities.

The official journal of CSACI

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.5
    Source Normalized Impact per Paper (SNIP): 0.904
    SCImago Journal Rank (SJR): 0.749

    Speed 2023
    Submission to first editorial decision (median days): 18
    Submission to acceptance (median days): 140

    Usage 2023
    Downloads: 1,545,686
    Altmetric mentions: 2,123